Strategically Focused Vascular Disease Research Network

Funding Agency:
American Heart Association

The American Heart Association announces a Request for Applications for the Strategically Focused Vascular Disease Research Network. 

Vascular diseases, including atherosclerotic peripheral vascular and aortic diseases are prevalent in the U.S. and other nations. More than 202 million people worldwide suffer from peripheral artery disease, including more than 8 eight million in the U.S. It affects approximately 12-20% of individuals older than age 60. Additionally, individuals with PAD suffer about a 5 percent annual rate of major adverse cardiovascular events. If left untreated or inadequately treated, these disorders may become life-threatening and disabling.  

This Strategically Focused Research Network provides AHA with a mechanism to enhance the understanding of the causes, biology, pathophysiology and epidemiology of these disorders, and to develop more effective ways to prevent and treat them with ultimate improvement in outcomes. Vascular Diseases, specifically Peripheral Artery Disease (PAD) and/or Aortic Disease, constitute a broad array of disorders, but applications responsive to this SFRN RFA must focus specifically on peripheral artery disease and aortic diseases in order to enhance synergy among centers and within the network. Applications focusing on other vascular diseases, such as: coronary artery disease; cerebrovascular disease; acute and chronic venous diseases including venous thromboembolism, venous insufficiency and varicose veins; pulmonary and systemic hypertension; vasospasm; lymphedema; or vasculitis will NOT be considered.

Institutions are limited to one Center application per location, however individuals at said institution who are not participating in said institution's Center application, may indeed participate in another Center's application.


  • Duke Internal Deadline: July 19, 2017
  • Letter of Intent: Aug. 1, 2017
  • Full Application: Sep. 26, 2017

Agency Website



Amount Description

Duration: 4 years with the opportunity for up to a 12-month No-Cost Extension.

Award Amount: The maximum budget amount an applicant may request is $3,709,200. The AHA reserves the right to determine the final award amount for competitive projects based on need and potential impact

Funding Type





Medical - Basic Science
Medical - Clinical Science
Medical - Translational

Internal Nomination

Owing to the sponsor's restriction on the number of applications that may be submitted from Duke, anyone wishing to pursue nomination should submit the following materials as one PDF.

* A letter of support from dean or chair - 1 to 1.5 pages
* Project summary - 2 to 4 pages
* CV or Biosketch of project leader

Please submit internal materials through My Research Proposal. (Code ILN)

Instructions for setting up your account and uploading internal applications can be found here: Instructions_FINAL.pdf

Internal Deadline

July 19, 2017

External Deadline

September 26, 2017